8-KMaterial AgreementsFinancial EventsOther Events+1

GE HealthCare Technologies Inc. 8-K Report, Material Agreement (Dec 15, 2025)

Filed December 15, 2025For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) has announced significant financing activities through an 8-K filing on December 15, 2025. The company has secured a new three-year, $750 million senior unsecured term loan credit facility. This facility offers flexibility in interest rate options, allowing GEHC to choose between an alternate base rate or a SOFR rate, with applicable margins tied to its senior unsecured long-term debt ratings. In parallel, GEHC successfully issued $1.35 billion in senior unsecured notes, comprising $600 million of 4.150% Senior Notes due 2028 and $650 million of 4.950% Senior Notes due 2035. The combined proceeds from the term loan and these notes, along with existing cash, are earmarked to fund the previously announced acquisition of Intelerad Medical Systems. These financing actions indicate strategic moves to support growth initiatives and enhance the company's capital structure.

Key Highlights

  • 1GE HealthCare secured a new $750 million senior unsecured term loan credit facility with a three-year maturity.
  • 2The term loan offers flexible interest rate options, including alternate base rate or SOFR, with margins linked to debt ratings.
  • 3The company issued $1.35 billion in senior unsecured notes: $600 million at 4.150% due 2028 and $650 million at 4.950% due 2035.
  • 4Proceeds from the term loan and notes will be used to finance the acquisition of Intelerad Medical Systems.
  • 5The financing activities involve standard covenants and events of default, customary for such debt agreements.
  • 6The notes are senior unsecured obligations, ranking equally with other existing senior unsecured debt.

Frequently Asked Questions

The primary purpose of these financing arrangements, including the $750 million term loan and the $1.35 billion in senior notes, is to fund the acquisition of Intelerad Medical Systems, as previously announced by GE HealthCare.

GE HealthCare issued $600 million of 4.150% Senior Notes due December 15, 2028, and $650 million of 4.950% Senior Notes due December 15, 2035. Interest payments are semi-annual, and the notes are senior unsecured obligations of the company.

The Company has the option to select an interest rate based on either an alternate base rate or a term SOFR rate for one-, three-, or six-month periods. The applicable margin will be determined by a pricing schedule based on GE HealthCare's senior unsecured long-term debt ratings.

Yes, the Term Loan Credit Agreement includes customary covenants that limit the Company's ability to incur liens, engage in certain fundamental change transactions, and maintain a maximum leverage ratio. It also restricts subsidiary indebtedness. Standard events of default are also included.